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ACVRL1/ALK1site for feline leukemia virus (FeLV), termed ﬂit-1, was identiﬁed from feline
thymic lymphoma. Among 35 FeLV-related tumors examined, 5 of 25 thymic lymphomas demonstrated
proviral insertion within ﬂit-1 locus whereas none of four alimentary and ﬁve multicentric lymphomas and
one T-lymphoid leukemia examined had rearrangement in this region. Extensive sequence analysis has
shown that ﬂit-1, which is noncoding, is conserved on human chromosome 12 and mouse chromosome 15.
The human and murine homologs of ﬂit-1 are positioned approximately 30-kb upstream to activin-A
receptor type II-like 1 (ACVRL1/ALK1) gene. Expression of ACVRL1 mRNA was examined in two of ﬁve
lymphomas with ﬂit-1 rearrangement and detected in both of the two whereas normal thymuses and seven
lymphoid tumors without ﬂit-1 rearrangement had no detectable expression. Therefore, ﬂit-1 appears to
represent a novel FeLV proviral common integration domain that may inﬂuence lymphomagenesis as
insertional mutagenesis.
© 2009 Elsevier Inc. All rights reserved.IntroductionRetroviruses are associated with a variety of malignancies and
provide powerful model systems for probing the biological and
molecular mechanisms of tumorigenesis. For nonacute transforming
type-C retroviruses such as feline leukemia virus (FeLV), the induction
of tumors involves long latency period and multiple cooperative
changes in growth control mechanisms (Fujino et al., 2008). Proviral
insertional mutagenesis is well accepted as one of the most important
steps in the process of retroviral tumorigenesis. Insertions near
oncogenes occur by chance as a consequence of the normal viral life
cycle (Mikkers and Berns, 2003). However, when a provirus integrates
near a gene controlling growth and alters its expression, the host cell
may have a selective growth advantage. Expansion of this cell
eventually leads to the formation of a clonal tumor. Pioneering studies
of avian leukosis virus (ALV)-induced bursal lymphomas revealed that
c-myc proto-oncogene is activated by proviral integration and there-
fore initiated extensive studies of this oncogene and many others
(Hayward et al., 1981). Studies with rodents have also identiﬁed moreInternal Medicine, Graduate
okyo, 1-1-1 Yayoi, Bunkyo-ku,
jino).
l rights reserved.than a hundred integration sites by murine leukemia virus (MuLV)
(Mikkers and Berns, 2003).
Compared to MuLV studies, only a few FeLV integration sites have
been identiﬁed (Fujino et al., 2008). FeLV is a replication-competent
type-C retrovirus that is associated with a variety of neoplastic
diseases in domestic cats, of which T-cell lymphoma is the most
common form (Fujino et al., 2003, 2004; Linenberger and Abkowitz,
1995; Neil et al., 1991). Like other mammalian leukemia retroviruses,
common subgroups of FeLV carry no transforming gene in its genome
with the exception of minor variants containing myc (Fujino et al.,
2008; Linenberger and Abkowitz, 1995). One mechanism of FeLV
tumorigenesis is believed to be due to the interactions between viral
and host genetic information, such as insertional mutagenesis (Fujino
et al., 2003, 2008; Hisasue et al., 2000, 2001; Linenberger and
Abkowitz, 1995; Neil et al., 1991; Roy-Burman, 1995).
Early studies have gathered evidence indicating that c-myc proto-
oncogene was activated by either viral transduction or proviral
insertional mutagenesis (Forrest et al., 1987; Levy et al., 1993b, 1984;
Miura et al., 1987, 1989; Neil et al., 1984; Tsatsanis et al., 1994). By
studying the genetic loci interrupted by proviruses in tumors induced
by FeLV-myc viruses, two other common integration sites were
identiﬁed. One of these was ﬂvi-2, which was interrupted by FeLV in
about 24% T-cell lymphomas (Levy and Lobelle-Rich, 1992; Levy et al.,
1993b; Tsatsanis et al., 1994). It was later proved to be a feline
orthologue of bmi-1, which encoded a gene for a nuclear protein of the
Fig. 1. Restriction endonuclease map of clone A5 and strategy of subcloning into pBS
vector. The empty boxes indicate the cellular regions ﬂanking the cloned proviral
sequence, which is shown in dashed box. The solid lines represent the ﬁrst pBS vector,
and the broken lines indicate the vectors used for subcloning. The orientation of the
provirus is as shown. The 5′ cellular fragment was cloned into EcoRI–KpnI sites of pBS.
The 3′ cellular regionwas ﬁrst cloned into pBS using the KpnI sites. Subsequently, the 3′
cellular fragment was double digested into two pieces with KpnI and HindIII and cloned
into pBS separately. Symbols: E, EcoRI; K, KpnI; H, HindIII; P, PstI; X, XhoI; S, SstI.
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act as a myc collaborator in the induction of B- and T-cell lymphomas
(Haupt et al., 1991; Levy et al., 1993a; van Lohuizen et al., 1991).
Another site, ﬁt-1, was only shown to be interrupted in 8% of tumors
(Tsatsanis et al., 1994). Although its coding potential has not been
characterized, the provirus inserted in this site has been demonstrated
to exert a long-range effect on feline orthologue of c-myb proto-
oncogene (Barr et al., 1999; Hanlon et al., 2003; Tsujimoto et al., 1993).
Besides these two loci, pim-1, which is a common integration site by
MuLV and encodes an oncogenic serine/threonine kinase, was also
shown to be frequently interrupted in FeLV-induced tumors (Tsatsanis
et al., 1994; Wang et al., 2001). Additionally, an uncharacterized locus,
ﬂvi-1, has been shown to be interrupted by FeLV insertion in some
feline lymphomas of the spleen (Levesque et al., 1990, 1991). Overall,
much fewer FeLV common integration sites have been identiﬁed in
lymphoid tumors as compared to MuLV studies. Therefore, the
identiﬁcation of important common integration sites and correspond-
ing cellular proto-oncogenes in FeLV-induced lymphomas and the
exploration of the functional roles of their gene products remain very
important in unraveling themechanisms of FeLV tumorigenesis. These
studies, in turn, may lead to the discovery of orthologous genes
important in tumorigenesis in human and thus contribute to a better
understanding of retroviral tumorigenesis in human. In this regard,
we initiated the present study and characterized a new common
integration site by FeLV in thymic lymphomas.Table 1
FeLV-positive feline lymphomas examined in the present study
Source Number examined Number with ﬂit-1 insertion
Thymic lymphoma (T-cell)
Natural 11 2 (18%)
Experimental (FeLV-A/Rickard) 12 3 (25%)a
Cell line (FT-1, KO-1) 2 0
Multicentric lymphoma
Natural 5 0
Alimentary lymphoma
Natural 4 0
T-lymphoid leukemia
Cell line (FL-74) 1 0
a One of these also exhibits c-myc insertion.Results
Identiﬁcation of a new FeLV proviral integration site in a
thymic lymphoma
The insertional mutagenesis hypothesis implicates that slow
retroviruses, which do not carry oncogenes in their genomes, induce
tumors by integrations into particular loci in host DNA thereby
increasing or interrupting expression of cellular genes. Consistent
ﬁndings of proviral sequences around the same locus in different
tumors suggest this locus may encode a gene that is important in the
multistep process of tumorigenesis (Mikkers and Berns, 2003). To
search for such loci, cloning of proviral integration sites from one
thymic tumor was attempted. A phagemid DNA library was estab-
lished by linking λ DASH II vector to the EcoRI digested genomic DNA
fragments that were prepared from a thymic tumor of cat 4746-5.
EcoRI restriction enzyme was used to obtain the proviral sequences
along with the cellular ﬂanking regions because there was no EcoRI
restriction site in all known FeLV proviral clones. The resulting phage
DNA library was then screened with the exU3 probe that is speciﬁc forall known exogenous FeLV LTR sequences (Fujino et al., 2003, 2004;
Hisasue et al., 2000; Miura et al., 1989).
With this strategy, two integration sites were identiﬁed. These two
fragments in λ DASH II were subsequently cloned into the EcoRI site of
pBS vector. Sequence analysis revealed that c-myc gene resided in one
of the cloned integration sites. Another clonewas named as A5 and the
restriction enzyme site map was shown in Fig. 1. To facilitate
identiﬁcation of the cloned integration site carried by clone A5, its
5′ cellular region was ligated to EcoRI–KpnI site of pBS, and the 3′
cellular region to the KpnI–KpnI site. The clone containing 3′ cellular
region was further cut into two pieces and cloned into KpnI–HindIII
and HindIII–KpnI sites of pBS (Fig. 1). Sequences within different
fragments were determined ﬁrst by primers on the pBS vector. Then
various primers were designed based on these sequences for
progressive DNA sequencing.
The 5′ LTR of the integrated provirus was sequenced and the
comparison of its sequence with that of F6A, an FeLV subgroup A
provirus (Donahue et al., 1988), revealed that A5 harbored an
exogenous FeLV containing a 73-bp direct repeat around LTR core
region (data not shown). Sequencing env gene of the provirus
conﬁrmed that A5 carried the FeLV subgroup A provirus. These two
lines of evidence indicated that the cloned provirus was exogenous in
origin and was kept in the cat genome during the tumor formation.
Clone A5 carried about 6.5-kb cellular sequence with 2-kb ﬂanking
the 5′ provirus and 4.5-kb downstream of the 3′ provirus. Both 5′ and
3′ cellular regions (based on the orientation of the provirus) were
sequenced. Extensive search using the NCBI Genebank BLAST database
revealed no signiﬁcant homology to any known proto-oncogenes or
tumor suppressor genes.
Examination of the integration locus in other FeLV-induced tumors
If the cloned integration site is involved in the induction of tumors
by FeLV, then it is likely that this particular locus could also be
interrupted by proviruses in other independent FeLV-related tumors.
To test this possibility, naturally occurring FeLV-related lymphomas in
twenty independent cats, experimentally induced lymphomas in
eleven independent cats in addition to the lymphoma from cat 4746-5
and three T-lymphoid tumor cell lines were recruited (Table 1).
Among those, 23 were thymic lymphomas, 4 were alimentary
lymphomas, and 5 were multicentric lymphomas. T-cell tumor cell
lines included FL-74 derived from FeLV-related T-lymphoid leukemia
(Theilen et al., 1969), FT-1 derived from FeLV-related thymic
lymphoma (Miura et al., 1987) and KO-1 derived from FeLV-related
thymic lymphoma (Fujino et al., 2004). High molecular weight DNA
was isolated from these tumor tissues and cells and digested with
either SstI or EcoRI. SstI cuts twice in FeLV genome at the positions 634
and 3738 according to the F6A sequence, and EcoRI does not cut FeLV
provirus at all. DNA fragments were separated in 0.8% agarose gels and
Fig. 2. Southern blot analyses for ﬂit-1 insertion. High molecular weight DNAs were isolated and digested with either SstI or EcoRI. The resulting ﬁlters were then hybridized to a
probe representing the 5′ EcoRI–KpnI cellular region of clone A5 (A and B) or the LTR-U3 speciﬁc for exogenous FeLV (C). Five thymic lymphoma samples carried ﬂit-1 rearrangement
(A) due to the integration of FeLV proviruses (C). None of other lymphoma samples were observed with ﬂit-1 rearrangement (B). FeLV-positive twelve experimentally induced thymic
lymphomas (4746-5, 5022 and 5042 on A and C, and 1 to 9 on B), eleven naturally occurring thymic lymphomas (P6 and P15 on A and C, and 10 to 18 on B), ﬁve naturally occurring
multicentric lymphomas (19 to 23 on B), four naturally occurring alimentary lymphomas (24 to 27 on B) and three T-lymphoid tumor cell lines (28 of FL-74, 29 of FT-1 and 30 of KO-1
on B) were subjected. N stands for genomic DNA extracted from normal SPF cat fetus liver tissues as germline and FeLV-negative controls. The approximate molecular weight of
individual bands is marked at the side. Arrows denote the uninterrupted cellular fragments, and arrowheads indicate the rearranged regions due to the proviral integration (A).
Fig. 3. Southern blot analyses for common integration sites of FeLV. High molecular
weight DNAs were isolated and digested with either EcoRI or XhoI. The resulting ﬁlters
were then hybridized to a probe of c-myc, pim-1, ﬁt-1, ﬂit-1 or ﬂvi-2. Five thymic
lymphomas carrying ﬂit-1 insertion (1, 4746-5; 2, P6; 3, P15; 4, 5022; 5, 5042) and a
normal SPF cat fetus liver (N) as a germline control were subjected. One thymic
lymphoma sample (1, 4746-5) carried c-myc rearrangement. The approximate
molecular weight of individual bands is marked at the side.
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KpnI region of clone A5. As shown in Figs. 2A and B, the probe
recognized normal SstI fragments of approximately 9.6-kb in SPF fetus
and all tumor tissues. In the 4746-5 and P6 tumor DNA samples,
additional 4.0-kb and 7.5-kb fragments were identiﬁed, respectively
(Fig. 2A). Similarly, while the same probe recognized normal cellular
EcoRI fragments of approximately 6.4-kb in the normal and tumor
tissues (Figs. 2A and B), altered fragments of 8.5-kb, 4.3-kb and 4.3-kb
were also identiﬁed in the P15, 5022 and 5042 tumor DNAs,
respectively (Fig. 2A). Therefore, including the original tumor where
the A5 was cloned, ﬁve independent thymic lymphomas showed
rearrangement around this locus (Table 1). Meanwhile, the mem-
branes that had all the tumor DNA samples were stripped and
rehybridized with the exU3 probe. This exogenous-speciﬁc proviral
LTR-U3 probe also identiﬁed the additional bands aside from the
normal cellular fragments (Fig. 2C). The additional 4.3-kb bands in
5022 and 5042 tumor DNAs were shown to be included proviral or
cellular genomes with some nucleotide change or deletion because
standard exogenous FeLV isolates had no EcoRI site and thus they are
usually detected as bands longer than 8.5-kb. These results indicated
that the integration site carried by clone A5 is a common proviral
integration site in FeLV-induced tumors. This locus has been named as
ﬂit-1, an acronym for feline leukemia virus integration site in thymic
lymphoma-1.
To exclude the possibility that ﬂit-1 may carry known common
FeLV proviral integration sites in the ﬂanking region, ﬂit-1 was
compared with c-myc, pim-1, ﬂvi-2, ﬂvi-1 and ﬁt-1. Although
approximately 10-kb of both 5′ and 3′ ﬂanking sequences of ﬂit-1
(GenBank/EMBL/DDBJ accession number AB378061 and AB378062)
were isolated by the adaptor ligation-based PCR-mediated genome
walking strategy, they disagreed with feline sequences of c-myc
(Stewart et al., 1986) and pim-1 (GenBank/EMBL/DDBJ accessionnumber AB073748). Moreover, the membranes that had the tumor
DNA samples carrying ﬂit-1 insertion were stripped and rehybridized
with c-myc and pim-1 probes (Fig. 3). The results showed that four of
the ﬁve tumors carried the germline conﬁguration of c-myc and pim-1
and the size of them was different from that of ﬂit-1. The one tumor
from cat 4746-5 had the rearrangement of c-myc and germline
conﬁguration of pim-1. Meanwhile, several XhoI-digested SPF feline
fetus and tumor DNAs were hybridized to the ﬂvi-2/bmi-1 DNA probe
(Levy and Lobelle-Rich, 1992; Levy et al., 1993a,b) (Fig. 3). A 12-kb
germline fragment instead of the 11-kb ﬂit-1 band was detected. In
Fig. 4. Comparative genomic structure of the human chromosome 12q13 and mouse chromosome 15F1 surrounding ﬂit-1 domain. The FeLV proviral integration sites, ﬂit-1 (closed
boxes), which have been located by BLAST searching of the draft human and mouse genome sequences are also depicted. The open boxes indicate annotated genes from the public
domain of human andmurine sequences. Horizontal arrows represent the orientation of the genes. Diagonal lines drawn between the human andmurine orthologues indicate genes
of homology.
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are about 5.4-kb and 2.4-kb (Fig. 3), respectively (Levesque et al., 1990;
Tsujimoto et al., 1993), whereas ﬂit-1 EcoRI fragment is about 6.4-kb.
Therefore, ﬂit-1 is believed to be a novel integration site identiﬁed in
FeLV-induced thymic lymphomas.
Evolutionary conservation and chromosomal assignment of ﬂit-1
The FeLV insertion of ﬂit-1 locus in 5 independent thymic
lymphomas suggested that interruption of ﬂit-1 site may lead to
alteration of the expression of important cellular genes that are critical
in the control of cell growth and differentiation. Due to the lack of
complete feline genome sequences, Genome BLAST search using NCBI
Genebank human andmurine database was performed. Both 5′ and 3′
ﬂanking cellular regions including extended sequences of clone A5
were used as queries in the search. In the search using human genome,
one and three matches were yielded from 5′ and 3′ cellular query
sequences, respectively. All matches assigned ﬂit-1 locus to human
chromosome 12q13 (Fig. 4). The matching sequences were shown to
have 77 to 87% homology to corresponding human chromosome
sequences. In the search using murine genome, three matches were
yielded from 3′ cellular query sequences whereas there was no match
from the 5′ cellular sequence. The matches could be assigned to
mouse chromosome 15F1 (Fig. 4), which showed 83 to 88% homology
to the corresponding sequences. Since feline chromosome B4 is partly
conserved the synteny relationship with human chromosome 12 and
mouse chromosome 15 (O'Brien et al., 1999), feline ortholog of ﬂit-1 is
supposed to be mapped on feline chromosome B4 although
chromosomal assignment is needed. The human and murine homo-
logs of ﬂit-1 have been positioned approximately 20-kb upstream to
ANKRD33 which is a hypothetical gene and predicted to encode a
transcription factor containing ankyrin repeatmotifs. Since it has been
shown that provirus can exert long-range effect to the genes located
more than 100-kb away from the original integration site (Hanlon et
al., 2003), we also searched genes located 100-kb upstream or
downstream of ﬂit-1 locus. SCN8A which encodes a member of theFig. 5. Expression of ACVRL1 mRNA in various feline cells and tissues. Total RNA samples iso
104C1), thymuses of two SPF cats (C1T and C2T), three FeLV-related T-lymphoid tumor cell lin
5042, 5024, 5022, 5036 and 5035) were subjected to RT-PCR analysis for ACVRL1mRNA. Them
lymphomas of 5042 and 5022 that have FeLV provirus insertion in ﬂit-1 whereas it was und
mRNA was used as an internal control.voltage-gated sodium channel (Burgess et al., 1995), was found to be
located upstream of both human and murine ﬂit-1 loci. Downstream
of ﬂit-1 site, it was identiﬁed with two activin-A receptor genes,
ACVRL1 (ALK1) and ACVR1B (ALK4), encoding cell-surface receptors for
the transforming growth factor (TGF)-beta of ligands (Attisano et al.,
1993; ten Dijke et al., 1993), as well.
Altered cellular gene expression by FeLV insertion in ﬂit-1
Since identical genes are located near the ﬂit-1 site on human and
murine chromosomes, there could be homologous genes around ﬂit-1
on feline chromosomal DNA. One of the genes, ACVRL1 (GenBank/
EMBL/DDBJ accession number AB378063), was shown to be important
in the process of cell growth and differentiation. To investigate the
mRNA expression of the gene in normal and neoplastic lymphoid cells,
total RNA samples from a normal placenta of one SPF cat as a positive
control, thymuses of two SPF cats, two normal T-lymphoid cell lines,
three FeLV-induced T-lymphoid tumor cell lines and six independent
FeLV-induced thymic lymphoma tissues were subjected to RT-PCR
analysis. The mRNA expression of ACVRL1 was distinctly detected in a
placenta and lymphoma tissues of cat 5042 and 5022 that have FeLV
provirus insertion in ﬂit-1 whereas it was undetectable in thymuses,
all cell lines and other lymphoma tissues that have no FeLV provirus
insertion in ﬂit-1 (Fig. 5). The results obtained here indicated that the
expression of the cellular gene nearby ﬂit-1, e.g. ACVRL1, could be
positively inﬂuenced by the FeLV provirus insertion in ﬂit-1.
Discussion
One mechanism of slow retroviral tumorigenesis is proposed as
insertional mutagenesis where a provirus inserts near a cellular gene
that is important for cell differentiation or proliferation and leads to
aberrant cellular gene expression (Mikkers and Berns, 2003). As a
representative of this virus family, FeLV has been found to target
certain genetic loci in lymphomas of T-cell origin, such as c-myc, ﬂvi-1,
ﬂvi-2, pim-1, and ﬁt-1 (Fujino et al., 2008; Levesque et al., 1990; Levylated from a normal placenta of a SPF cat, two feline normal T-cell lines (MCH5-4 and
es (FL-74, FT-1 and KO-1), and six independent FeLV-induced thymic lymphomas (5051,
RNA expression of ACVRL1was distinctly detected in a placenta as a positive control and
etectable in the others that have no FeLV provirus insertion in ﬂit-1. RT-PCR for GAPDH
20 Y. Fujino et al. / Virology 386 (2009) 16–22and Lobelle-Rich, 1992; Miura et al., 1987; Tsatsanis et al., 1994;
Tsujimoto et al., 1993). The study here reported the identiﬁcation of a
novel common integration site by FeLV, named ﬂit-1, in thymic
lymphomas.
The ﬂit-1 locus was isolated from the experimentally induced
thymic lymphoma of cat 4746-5 that had been challenged by FeLV
Rickard strain subgroup A (Pandey et al., 1995; Sheets et al., 1992). The
provirus that resided within this locus was conﬁrmed to be exogenous
FeLV-A and contained an enhancer duplication of 73-bp around the
LTR-U3 core region. This tandem duplication could result from
mutation during the process of viral replication. There are several
studies that the tandem direct repeat around the core enhancer of the
FeLV LTR has been frequently observed in thymic lymphomas and
conferred an enhancer function upon gene expression (Chandhasin et
al., 2004; Miura et al., 1989; Nishigaki et al., 1997; Plumb et al., 1991),
suggesting its association with tumorigenic potential in lymphoid
cells.
Approximately 10-kb of both 5′ and 3′ cellular ﬂanking regions of
ﬂit-1 has been sequenced, respectively, and extensive Genebank
database search did not reveal signiﬁcant nucleotide homology of ﬂit-
1 with any of the known genes related to tumorigenesis including c-
myc and pim-1, also reported as FeLV common integration sites.
Hybridization and comparative analyses for previously identiﬁed FeLV
common integration sites of ﬂvi-1, ﬂvi-2 and ﬁt-1 were also shown to
light up different germline fragments from ﬂit-1. Therefore, ﬂit-1 is a
new FeLV integration site identiﬁed in the present study.
Total 35 FeLV-induced lymphoid neoplasms were examined and
carried no ﬂit-1 insertion of the FeLV provirus with the exception of
some thymic lymphomas. Interestingly, including the original tumor
from where the ﬂit-1 locus was isolated, the FeLV integration was
observed in 5 of 23 thymic lymphoma tissues (the frequency was
21.7%) and 25 thymic lymphomas including two cell lines (it was
20.0%) examined. Among these, the tumors from cat 4746-5, 5022 and
5042 were induced by challenging an FeLV-A Rickard strain prepara-
tion and only one from cat 4746-5 harbored proviral insertion near c-
myc gene. The tumors of P6 and P15 were naturally occurring thymic
lymphomas and contained no FeLV integration around c-myc. These
results indicate that (1) proviral integration into ﬂit-1 locus can be
associated with generation of thymic lymphoma in cats; (2) unlike
ﬂvi-2 or ﬁt-1 (Barr et al., 1999; Hanlon et al., 2003; Levy et al.,
1993a; Tsujimoto et al., 1993), gene product of ﬂit-1 insertion may not
have a direct collaborating function with c-myc.
Identiﬁcation of ﬂit-1 as a frequently targeted domain of FeLV
integration in thymic lymphoma suggests that ﬂit-1 provides a
function in target cells which confers a selective growth advantage
or otherwise contributes to induce malignant transformation. In this
respect, it is likely that ﬂit-1 is located near a gene that is critical in the
control of cell growth and differentiation and the insertion may
inﬂuence expression of the gene. To identify key candidate gene(s)
involved in FeLV-related lymphomagenesis, extended ﬂanking regions
of ﬂit-1 were sequenced and Genome Blast search was performed
using human and mouse genome database. It was demonstrated that
ﬂit-1 could be signiﬁcantly assigned to approximately 30-kb and 80-
kb upstream of ACVRL1 (ALK1) and ACVR1B (ALK4), respectively, and
50-kb downstream of SCN8A on both human chromosome 12q13 and
mouse chromosome 15F1. The ligand of both ACVRL1 and ACVR1B is
activin-A, which belongs to TGF-β superfamily and is a multi-
functional cytokine that regulates cell growth and differentiation
(Attisano et al., 1993; ten Dijke et al., 1993). The mutation of ACVRL1
has been closely related with hereditary hemorrhagic telangiectasia
(Johnson et al., 1996; Urness et al., 2000). The analysis of mRNA
expression indicated that upregulated expression of ACVRL1 by FeLV
insertion into ﬂit-1 might contribute to obtain growth advantage of
the cell and thus be one of steps of tumorigenesis. This result can be a
pioneer that ACVRL1 may have potential to be associated with
tumorigenesis.The present study demonstrated that ﬂit-1 locus was a frequently
targeted genetic site in FeLV-induced thymic lymphomas and the
insertion might have an effect on expression of the nearby gene, such
as ACVRL1. The signiﬁcance to malignant induction of insertional
mutagenesis of these regionsmay be related to the action of particular
retroviruses or to the induction of particular tumor types. In further
studies, it becomes important to extend the functional study of nearby
genes in lymphoid tumor induction to other species, such as humans.
Materials and methods
Subgenomic cloning
Subgenomic library screening was performed as described pre-
viously (Fujino et al., 2001a,b). Genomic DNA was puriﬁed from the
thymic tumor tissue of cat 4746-5, which was challenged by an FeLV-A
Rickard strain preparation (Pandey et al., 1995; Sheets et al., 1992).
Since EcoRI does not cut into FeLV proviruses, a subgenomic library
was constructed by ligation of 8- to 20-kb EcoRI fragments to the λ
DASH II phagemid vector (Stratagene, La Jolla, CA). The exU3, which is
speciﬁc for the U3 region of all known exogenous FeLV long terminal
repeat (LTR) sequences (Fujino et al., 2003, 2004; Hisasue et al., 2000;
Miura et al., 1989), was used as a probe to screen the phage library.
Proviral clones containing cat genomic sequences were identiﬁed and
subcloned into pBluescript (pBS) vector (Stratagene). One of the
clones, A5, was determined later in this study to harbor a frequently
targeted genetic locus by FeLV integration by Southern blot analysis.
For further sequence analysis, a 5′ cellular sequence of A5 was
subcloned into EcoRI–KpnI site of pBS vector, and a 3′ cellular region
was ﬁrst cloned into the KpnI–KpnI site of pBS vector and then
subsequently cloned into KpnI–HindIII and HindIII–KpnI sites of pBS
vectors, respectively. Sequences within individual fragment subcloned
from the A5 plasmid were determined ﬁrst by primers T3 and T7 on
the pBS vector. Multiple primers were subsequently designed based
on these sequences for further sequencing analysis.
Southern blot analysis
Highmolecular weight genomic DNA samples were extracted from
naturally occurring or experimentally induced thymic, alimentary, or
multicentric lymphomas of 32 independent FeLV infected cats, FL-74
(Theilen et al., 1969), FT-1 (Miura et al., 1987) and KO-1 (Fujino et al.,
2004) cells, and several speciﬁc pathogen free (SPF) feline fetus liver
tissues. These specimens were treated with a lysis buffer containing
0.02 mg of proteinase K per ml, 0.01 M Tris–hydrochloride (pH 8.0),
1 mM ehthylenediamine tetraacetic acid (EDTA), 0.5% sodium dodecyl
sulfate (SDS) and 0.01mg of RNase A per ml at 37 °C for 24 h. Then, the
DNA samples were extracted with phenol and chloroform, and
precipitated with ethanol. The DNA samples (15 μg/lane) were
digested with 100 U of restriction enzymes EcoRI or SstI, electro-
phoresed through 0.8% agarose gels, and transferred onto nylon
membranes. The DNA samples on the membranes were hybridized
with a 32P-labelled A5-5 probe, which was the 5′ EcoRI–KpnI cellular
fragment of A5 clone, in a hybridization solution containing 5× SSC, 1%
SDS, 0.05 M Tris–hydrochloride (pH 7.6), 0.1 mg of salmon sperm DNA
(Sigma, St. Louis, MO) per ml and 5× Denhardt's solution (1×
Denhardt's solution consisted of each 0.02% of Ficoll type 400,
polyvinyl pyrrolidine and bovine serum albumin fraction V) at 62–
65 °C for 16 h. After hybridization, the ﬁlters were washed 3 times
with a solution containing 1× SSC and 0.1% SDS at 57–60 °C for 30 min
and subjected to autoradiography. The blots that contain the DNA
samples with its rearrangement were stripped and hybridized to the
exU3 probe. Some of the membranes were also stripped and
hybridized with c-myc, ﬁt-1, ﬂvi-2 and pim-1 probes (Levy and
Lobelle-Rich, 1992; Levy et al., 1993a; Tsatsanis et al., 1994; Tsujimoto
et al., 1993), respectively. The feline pim-1 cDNA has been cloned
21Y. Fujino et al. / Virology 386 (2009) 16–22previously (GenBank/EMBL/DDBJ accession number AB073748), and
its probe was generated based on the feline sequence.
Adaptor ligation-based PCR-mediated genome walking
The isolation of the unknown 5′ and 3′ cellular ﬂanking sequences
of clone A5 were achieved using an adaptor ligation-based PCR-
mediated genome walking strategy. This splinkerette allows the
ampliﬁcation between a primer annealing in a known part of the
sequence and a nearby restriction site laying out of the known part of
the sequence (Devon et al., 1995). The protocol has been modiﬁed
from its original; in that way that the restriction enzyme BamHI,
EcoRI, HindIII, PstI and XbaI were used to create an overhang for
ligation of the corresponding splinker. Annealing of splinkers was
achieved by heating proper amounts of splnktop (5′ CGA ATC GTA ACC
GTT CGT ACG AGA ATT CGT ACG AGA ATC GCT GTC CTC TCC AAC GAG
CCA AGA 3′) with splnk BamHI (5′ GAT CTC TTG GCT CGT TTT TTT TTG
CAA AAA 3′), splnk EcoRI (5′ AAT TTC TTG GCT CGT TTT TTT TTG CAA
AAA 3′), splnk HindIII (5′ AGC TTC TTG GCT CGT TTT TTT TTG CAA AAA
3′), splnk PstI (5′ ACG TTC TTG GCT CGT TTT TTT TTG CAA AAA 3′) or
splnk XbaI (5′ CTA GTC TTG GCT CGT TTT TTT TTG CAA AAA 3′) (20 μM
each) in 20 μl of Tris, pH 7.4 and 5 mM MgCl2 at 90 °C and cooling on
the bench top for 20 min. A volume of 5 μg genome DNAwas digested
in a 20 μl reaction volume with 10 U of a same restriction enzyme as
the adaptor for 16 h at 37 °C. The reaction was terminated by heat
inactivation for 15 min at 90 °C. Four microliters of the digested DNA
(1 μg) and 6 μl of the annealed splinkerweremixedwith 1 U of T4 DNA
ligase in a ﬁnal volume of 20 μl, incubated overnight at 15 °C and then,
terminated for 20 min at 80 °C. A nested PCR was performed for
ampliﬁcation of the desired fragments. The primer splk0 (5′
CGAATCGTAACCGTTCGTACGAGAA 3′) was used in the ﬁrst PCR,
which annealed to the complement of the longer strand that was
generated in the ﬁrst PCR cycle by priming of a gene-speciﬁc primer.
The primer splk1 (5′ TCGTACGAGAATCGCTGTCCTCTCC 3′) was used in
the second PCR, togetherwith the nested gene-speciﬁc primer. Each of
the gene-speciﬁc primers was subsequently designed based on
obtained ﬂanking sequences of A5. PCR was performed in a volume
of 50 μl containing 1 μl of the adaptor-ligated DNA digests (50 ng), a
pair of primers (0.2 μM each), 1 U of Elongase (Invitrogen, Carlsbad,
CA) and the reaction buffer as recommended by the supplier. The
reaction mixture was incubated for 2 min at 94 °C, followed by 30
cycles: 1 min at 94 °C, 1 min at 55 °C and 10min at 68 °C. The resulting
products were electrophoresed on 1% agarose gels and extracted from
the gels. The cloning of these DNA fragments was facilitated by using
TA-cloning kit (Invitrogen). Plasmids were recovered using a QIAprep
Spin Miniprep kit (QIAGEN, Valencia, CA) and sequenced. The isolated
sequences were analyzed by using the BLASTn program, National
Center for Biotechnology Information (NCBI, www.ncbi.nlm.nih.gov/).
Reverse transcriptase (RT) PCR
Total RNA was extracted from a normal placenta of one SPF cat,
independent tumor tissues of FeLV-induced thymic lymphoma in six
cats which was challenged by an FeLV-A Rickard strain preparation,
thymuses of two SPF cats, two feline normal T-cell lines of MCH5-4
and 104-C1 (Lerner et al., 1998), and three FeLV-related T-lymphoid
tumor cell lines of FL-74, FT-1 and KO-1 using Trizol reagent
(Invitrogen). After removal of DNA contamination using DNase I,
0.5 μg of total RNA was reverse-transcribed using SuperScript III
Reverse Transcriptase (Invitrogen) in the presence of oligo(dT).
Primers to amplify the partial fragment of activin-A receptor type II-
like 1 (ACVRL1/ALK1) cDNA were designed based on the sequences of
human andmouse homologs (GenBank/EMBL/DDBJ accession number
BC042637 for human and CT010330, BC014291 and BC015083 for
mouse). The reaction for the feline house-keeping GAPDH gene
(GenBank/EMBL/DDBJ accession number AB038241) was used as aninternal control. The primers were designed based on the identiﬁed
sequence to cross an intron as follows: sense primer (5′ GCTT-
CATCGCCTCAGACAT 3′) and antisense primer (5′ CAATGTGCTGGT-
CAAGAGCAAC 3′) for ACVRL1 cDNA, and sense primer (5′
CTCATGACCACAGTCCATGC 3′) and antisense primer (5′ TGAGCTTGA-
CAAAGTGGTCA 3′) for GAPDH cDNA. PCR was performed as described
above. The reactionmixturewas incubated for 1min at 94 °C, followed
by 30 cycles: 1 min at 94 °C, 30 s at 55 °C and 1 min at 68 °C. The
ampliﬁed products were electrophoresed on 2% agarose gels and
visualized by staining with ethidium bromide. To conﬁrm the
sequence, these DNA fragments were extracted from the gels, cloned
and sequenced as described above.
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